3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Neuroblastoma
2
Melanoma
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia
2
Endometrial Neoplasms
2
Congenital Abnormalities
2
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Pleuropulmonary blastoma
1
Papillomavirus Infections
1
Pain
1
Neurofibrosarcoma
1
Neoplasms
1
Myeloproliferative Syndrome, Transient
1
Meningioma
1
Malignant mesenchymal tumor
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Liposarcoma
1
Leukemia, Eosinophilic, Acute
1
Interventions
Specimen Handling
1
Observation
1
Medical Marijuana
1
IMM-101
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
COVID-19
×
Observation
×
Clear all
NCT04442048
2025-12-30
COV-IMMUNO
Canadian Cancer Trials Group
Phase 3
Completed
195 enrolled